| Literature DB >> 30352206 |
Vanesca P A de Arruda1, Maria A Bellomo-Brandão2, Joaquim M Bustorff-Silva3, Elizete Aparecida Lomazi4.
Abstract
OBJECTIVE: To compare the clinical evolution in patients with refractory functional constipation undergoing different therapeutic regimens: oral laxatives and antegrade enemas via appendicostomy or clinical treatment with oral laxatives and rectal enemas.Entities:
Keywords: Adolescent; Adolescente; Child; Constipação intestinal; Criança; Enema; Fecal incontinence; Functional constipation; Incontinência fecal
Mesh:
Substances:
Year: 2018 PMID: 30352206 PMCID: PMC9432165 DOI: 10.1016/j.jped.2018.09.001
Source DB: PubMed Journal: J Pediatr (Rio J) ISSN: 0021-7557 Impact factor: 2.990
Duration and type of treatment for constipation in 28 patients with refractory functional constipation, classified according to the type of treatment: appendicostomy or clinical treatment.
| Median (min–max) | Total | Type of treatment | ||
|---|---|---|---|---|
| Appendicostomy | Clinical | |||
| Duration of constipation until referral to the tertiary service (years) | 5 (1.3–10.6) | 5.4 (1.3–9.7) | 5 (2–10.6) | 0.62 |
| Total time of FC (previous history + tertiary service) (years) | 11.4 (4.4–18.3) | 12 (6.4–18.3) | 10.8 (4.4–16) | 0.20 |
| Follow-up time in the specialty until final evaluation (years) | 5.7 (1.7–12) | 6.4 (2.4–12) | 4 (1.7–7) | 0.008 |
| Time of follow-up after the therapeutic option (years) | 3.3 (0.7–6) | 2.6 (1.4–5) | 3 (0.7–6) | 0.40 |
FC, functional constipation.
Mann–Whitney.
Figure 1Percentage of patients with retentive fecal incontinence at 6, 12, 24 months and final evaluation after choice of treatment: appendicostomy or clinical treatment.
Clinical symptoms assessed at follow-up of 28 patients with refractory functional constipation, distributed according to the type of treatment: appendicostomy or clinical treatment.
| Assessments | Type of treatment | ||
|---|---|---|---|
| Appendicostomy ( | Clinical ( | ||
| RFI with the use of enemas | 6 (35.3%) | 11 (100%) | 0.001 |
| Control of RFI with the use of enemas | 11 (64.7) | 0 (0.0%) | |
| Spontaneous regular bowel movements | 0 (0.0%) | 0 (0.0%) | |
| RFI with the use of enemas | 3 (17.6%) | 11 (100%) | 0.001 |
| RFI control with the use of enemas | 14 (82.4%) | 0 (0.0%) | |
| Spontaneous regular bowel movements | 0 (0.0%) | 0 (0.0%) | |
| RFI with the use of enemas | 2 (11.8%) | 8 (72.7%) | 0.005 |
| RFI control with the use of enemas | 13 (76.4%) | 3 (27.3%) | |
| Spontaneous regular bowel movements | 2 (11.8%) | 0 (0.0%) | |
| RFI with the use of enemas | 2 (12.5%) | 6 (54.6%) | 0.043 |
| RFI control with the use of enemas | 5 (32.3%) | 1 (9.0%) | |
| Spontaneous regular bowel movements | 9 (56.2%) | 3 (27.4%) | |
One patient was lost to follow-up 3.6 years after the appendicostomy.
One patient was lost to follow-up after 2.1 years of follow-up.
Time of follow-up after therapeutic option:
Appendicostomy: 2.5 years (1.4–5) clinical treatment: 3 years (0.8–6).
RFI, retentive fecal incontinence.
Fisher's exact test.
Outcomes according to colonic transit pattern in patients with refractory functional constipation and treated with appendicostomy or clinical treatment.
| Type of treatment | Total | Colonic transit | ||
|---|---|---|---|---|
| DR | SCT | |||
| RFI with the use of enemas | 3 (17.7%) | 1(14.3%) | 2 (20.0%) | 1.00 |
| RFI control with the use of enemas | 5 (29.4%) | 2 (28.5%) | 3 (30.0%) | |
| Regular bowel movement | 8 (47.0%) | 4 (57.2%) | 4 (40.0%) | |
| RFI with the use of enemas | 6 (54.5%) | 4 (57.1%) | 2 (50.0%) | 0.87 |
| RFI control with the use of enemas | 1 (9.0%) | 1 (14.3%) | 0 (0.0%) | |
| Regular bowel movement | 3 (27.2%) | 1 (14.3%) | 2 (50.0%) | |
DR, distal retention; SCT, slow colonic transit; RFI, retentive fecal incontinence.
One patient was lost to follow-up 3.6 years after the appendicostomy.
One patient was lost to follow-up after 2.1 years of follow-up.
Fisher's exact test.